IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-2.2%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+3.3%)
Cap. Flow
+$42.3M
Cap. Flow
% of AUM
11.19%
Top 10 Holdings %
Top 10 Hldgs %
55.17%
Holding
61
New
9
Increased
14
Reduced
9
Closed
5
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$17.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$15.3M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$11.5M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.37M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$15.5M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$14.5M |
| 3 |
Halozyme
HALO
|
$11.4M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11M |
| 5 |
Amgen
AMGN
|
$7.22M |
Sector Composition
| 1 | Healthcare | 96.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Axsome Therapeutics
AXSM
$6.05B
| $793K | 0.21% | 14,000 | – | – |
|
52
FibroGen
FGEN
$47.8M
| $684K | 0.18% | 19,700 | – | – |
|
53
Travere Therapeutics
TVTX
$1.56B
| $499K | 0.13% | 20,000 | – | – |
|
|
BLUE
54
DELISTED
bluebird bio
BLUE
| $332K | 0.09% | 11,000 | – | – |
|
55
Esperion Therapeutics
ESPR
$448M
| $266K | 0.07% | 9,500 | – | – |
|
56
AnaptysBio
ANAB
$569M
| $216K | 0.06% | 10,000 | – | – |
|
57
Mersana Therapeutics
MRSN
$36.5M
| – | – | -72,000 | Closed | -$1.91M |
|
|
ZEAL
58
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| – | – | -5,653 | Closed | -$203K |
|
|
ALXN
59
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – | -99,241 | Closed | -$15.5M |
|
|
GWPH
60
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – | -10,200 | Closed | -$1.18M |
|